Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Academic Article uri icon

Overview

MeSH Major

  • Clinical Competence
  • Competency-Based Education
  • Education, Distance
  • Education, Medical, Continuing
  • Physicians

abstract

  • Histologic remission rates for current UC treatments ranged from 15.0% to 44.9% according to drug class and patient population with the highest rates observed for topical aminosalicylates. Placebo remission rates were low with relatively narrow CIs. These data provide benchmarks to inform future trial design. Histologic remission is a potential treatment target in clinical practice.

publication date

  • May 2019

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.14309/ajg.0000000000000111

PubMed ID

  • 30694863

Additional Document Info

start page

  • 733

end page

  • 745

volume

  • 114

number

  • 5